This anniversary celebrates us, but we wouldn’t be here without you. Join us as we pay tribute to the people, events and partners that make us Clario.
The landscape of clinical trials and clinical endpoints is evolving quickly. To stay ahead, we hire people who are extraordinary at what they do—and cultivate an environment where they can grow and make an impact.
By embracing the information, insights and inspiration that guides us, we step forward, unafraid of trying new things and pushing for better outcomes in technology, operations and patient experience.
We step forward because responsibility powers us; we don’t leave others to do what we can do ourselves. We take charge of events, delivering exceptional work for our customers, patients and each other.
I left my cardiology practice to join Clario in order to do my lifelong mission: The prevention of sudden cardiac death. As a practicing physician, I was able to do this one patient at a time. But Clario’s cardiac safety work does this for millions of patients at a time – for each new drug that we touch. That’s a calling, not a job.
Robert Kleiman – Chief Medical Officer, VP of Global Cardiology
The first drug that I worked on and was approved, was fluticasone propionate nasal spray, or “Flonase” back in 1998. I was responsible for the bone safety study using the DXA central laboratory service. I recall seeing Flonase in the supermarket pharmacy and telling my two young children that I had worked on the approval for that drug—I was very proud to show them what their dad did.
Ken Gaither, Ph.D. – VP of Medical Imaging
Explore just a fraction of the thousands of remarkable people and events that have empowered us to grow, change and further our mission of unlocking better clinical evidence.